ACOR drops 25%

Discussion in 'Acorda Therapeutics' started by anonymous, Sep 10, 2018 at 7:52 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    You are so full of crap that I can smell it in Ardsley. You idiot creature dont know what you talk about ok. So management here is great and we will prosper
     
  2. anonymous

    anonymous Guest

    You keep telling us this Habib. Evidence as usual says otherwise.

    I know evidence confuses you. Here’s some help. It’s the thing you won’t have that shows inhaled LD is any more effective than generics.

    You are right about one thing. Management at ACOR is great about lining their pockets and avoiding accountability.
     
  3. anonymous

    anonymous Guest

    So much racism and hatred toward Indian-Americans being expressed on various posts.

    Hang-in there Habib, we love you !
     
  4. anonymous

    anonymous Guest

    You will stabilize at $13 a share and lucky to get a buyout at $16... grad ur life vest or go down with ship. Hope is not a business strategy ...
     
  5. anonymous

    anonymous Guest

    The place is a cesspool.Get OUT!!!!!!!!!!!!!! :eek:
     
  6. Habib

    Habib Guest

    Has anyone gotten hired in the last 6 months? Sounds like people are only leaving
     
  7. anonymous

    anonymous Guest

    Just the interns. According to their posts, they have fixed the whole place. Their writing is a bit choppy but we try to let it slide or they scream racism.
     
  8. anonymous

    anonymous Guest

    Make your own decision and check the launch trajectory of another inhaled rx approval... afreeza. It tanked even with a co-promote and better quality managed market team and eventually sank to under $1. Hope and hype is not a business strategy . Liquidate equity while u can before it drops to < $10
     
  9. anonymous

    anonymous Guest

    F YOU. Leadership on target with inhaled LD. So ok BUY ACOR now!!!.

    great CEO, great Team, great Pipeline!!!!
     
  10. anonymous

    anonymous Guest

    Leadership fumbled the lifecycle planning of a product that was already commercialized. With no contingency plan when it imploded. Now hinging next chapter on a hopeful approval then create a market. We had a product, market share and revenue.... all we have now is a dream and hype. I will make a prediction.... even if it gets approved I can guarantee 8k filings of insider selling will be at an all time high.... what message will that send.... will be in a dumping syndrome.
     
  11. anonymous

    anonymous Guest

    Change scares the weak and gives adrenaline to the strong. Do you smell the fear coming from the weakest link in the chain. Yes it stinks ! Cafepharma is where these weaklings gather to stew in their stink.

    Fortunately, Acorda is made of stronger stuff. My friends are enargized, challenged, motivatived, cheerful, and greatful for how our leaders have navigated the shifting sands of our industry.

    Stand tall and be proud. Our strong leaders will overcome any change.
     
  12. anonymous

    anonymous Guest

    Habib, you can try and reclassify failure and ineptitude all you want, however the facts remain the same. Management bungled LCM and the regulatory approach to a non essential product that will impact revenue.

    Change is indeed in the air, however it’s not the change you profess. Sooner or later, leadership will have to answer for their mistakes. The question is how many will they take down with them?

    There is no accelerated approval for inhaled LD (you are already past your PDUFA date).

    Keep up the lies, it only proves you have nothing to save this organization other than rhetoric and spin. Investors are watching closely.
     
  13. anonymous

    anonymous Guest

    ******************
    The above post is preposterous and shall be noted as mostly "BS". Leadership welcomes constructive criticism as well as well-thought out recommendations. Throwing out false 'know it all' posts is yet another dangerous behavior; before you post please look in the mirror and consider the damage you might do to a great Company.

    We are on track for a healthy rebound and accelerated approvals, international sales and an aggressive marketing campaign will fix all. Leadership is running ACOR 24/7.
    ******************
     
  14. anonymous

    anonymous Guest

    So in other words, it’s factual. Got it!
     
  15. anonymous

    anonymous Guest

    Ron, friendly advice here: time to put Andy (your banker, not the moron running BD) to work. ACOR is best in someone else's hands.